(Q46678012)

24 December 2017

title

Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels (English)

1 reference

24 December 2017

1 reference

6

1 reference

24 December 2017

Matthew P Galloway

10

1 reference

24 December 2017

author name string

Juan Bustillo

1

1 reference

24 December 2017

Ranee Barrow

2

1 reference

24 December 2017

Rodrigo Paz

3

1 reference

24 December 2017

Jennifer Tang

4

1 reference

24 December 2017

Navid Seraji-Bozorgzad

5

1 reference

24 December 2017

Federico Bolognani

7

1 reference

24 December 2017

John Lauriello

8

1 reference

24 December 2017

Nora Perrone-Bizzozero

9

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

24 December 2017

published in

Neuropsychopharmacology

1 reference

24 December 2017

volume

31

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

751-756

1 reference

24 December 2017

Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

Regional and developmental variations in metabolite concentration in the rat brain and eye: a study using 1H NMR spectroscopy and high performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

Emergence of oral and locomotor activity in chronic haloperidol-treated rats following cortical N-methyl-D-aspartate stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

Proton magnetic resonance spectroscopy (H-MRS) studies of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

Developmental and regional changes in the neurochemical profile of the rat brain determined by in vivo 1H NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

N-acetylaspartate in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

The rat model of tardive dyskinesia: Relationship between vacuous chewing movements and gross motor activity during acute and long-term haloperidol treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

7 January 2021

Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

7 January 2021

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

7 January 2021

Changes in caudate volume with neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

7 January 2021

Effects of antipsychotic drugs on metabolite ratios in rat brain in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

7 January 2021

Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

7 January 2021

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300874

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300874

1 reference

24 December 2017

Dimensions Publication ID

1019125987

0 references

1 reference

24 December 2017